Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

Sepsis is a global health priority affecting 55 million patients worldwide and causing 11 million deaths annually. Treatment for sepsis may include prompt recognition, source control, antibiotics, ...

Treatment with vasopressor medications was associated markedly increased risk for developing intensive care unit (ICU)-associated weakness among critically ill patients on mechanical ventilation, ...

Sepsis is a global health priority affecting 55 million patients worldwide and causing 11 million deaths annually. Treatment for sepsis may include prompt recognition, source control, antibiotics, ...

Higher rates of septic shock deaths occurred during quarters of norepinephrine shortage. When drug shortages happen in the United States, their impact on patient care and outcomes is not commonly ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--Vivacelle Bio, Inc., a privately held company focused on the development of improved treatments for septic shock, today announced early results from its Phase IIa ...

THE rationale for the use of vasopressor agents in the treatment of shock is controversial. The principal objection to their use is that during shock, sympathetic and adrenergic activity is increased ...

The Ethics' Committee waived the need for informed consent, as this was an observational study. We retrospectively analyzed the clinical, hemodynamic, and biological data of all patients consecutively ...

For patients with in-hospital cardiac arrest (IHCA), adding a vasopressor and steroid shortly after epinephrine improves return of spontaneous circulation (ROSC), according to the randomized VAM-IHCA ...

Background/Aims: Clinical protocols based on available evidence and supported by wide staff consensus are considered an effective means to introduce potentially better practices in the ...